All questions are shown as received by the Trust.
In the past three months, how many patients have been treated for Bladder cancer with the below:
a) Avelumab
b) Atezolizumab
c) Carboplatin with Gemcitabine
d) Carboplatin single or in any other combination
e) Cisplatin with Gemcitabine
f) Cisplatin single or in any other combination
g) Nivolumab
h) Pembrolizumab
i) Any other systemic anti-cancer therapy
j) Palliative care only
